Home/Filings/4/0001638599-18-001111
4//SEC Filing

Clasby Jennifer G 4

Accession 0001638599-18-001111

CIK 0001682639other

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 4:45 PM ET

Size

8.4 KB

Accession

0001638599-18-001111

Insider Transaction Report

Form 4
Period: 2018-09-10
Clasby Jennifer G
VP, Clinical Operations
Transactions
  • Exercise/Conversion

    Common Stock

    2018-09-10$1.95/sh+28,965$56,48228,965 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-09-10+28,96551,247 total
    Exercise: $1.95Exp: 2027-07-07Common Stock (28,965 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $6.20Exp: 2028-07-24Common Stock (19,874 underlying)
    19,874
Footnotes (2)
  • [F1]The option became exercisable as to 2,228 shares on August 7, 2017, and becomes exercisable in equal 2,228 share amounts on each of the 35 one-month anniversaries thereafter.
  • [F2]One-third of the option becomes exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24-one month anniversaries thereafter.

Issuer

EYENOVIA, INC.

CIK 0001682639

Entity typeother

Related Parties

1
  • filerCIK 0001728919

Filing Metadata

Form type
4
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 4:45 PM ET
Size
8.4 KB